NCT02563496: A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
- State
- Completed
- Phase
- Phase 2
- People
- 60 taking part
- Started
- 6 Feb 2017
- Primary completion
- 15 Dec 2019
- Arms
- Tafenoquine 50 mg, Tafenoquine 100 mg, Tafenoquine 150 mg, Tafenoquine 200 mg, Tafenoquine 300 mg
- Results
- Posted on the registry
- 30 Sep 2015: Trial registered
- 6 Feb 2017: Trial started
- 17 Feb 2020: Trial completed
- 2 Nov 2020: Trial results posted